Search

everythinglearnresearchcommunity

for

Search:↓

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

Certain changes in the VEGF gene can increase or decrease the risk of polycystic ovary syndrome.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

Spinach-derived thylakoid supplements plus a low-calorie diet helped obese women with polycystic ovary syndrome lose weight and improve their metabolism.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Most women with PCOS have insulin resistance, especially those with phenotype B.

Women with PCOS are more likely to develop kidney stones, especially those with certain PCOS types.

Cinnamon may help manage obesity and improve conditions related to Polycystic Ovary Syndrome (PCOS).

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

Hair and nails can show hormone changes during puberty in dogs.

The conclusion is that accurately replicating the complexity of the extracellular matrix in the lab is crucial for creating realistic human tissue models.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Some patients with high prolactin levels don't show symptoms because they have a form of the hormone that's less active.

Father's finasteride use may affect son's fertility and testicular function.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.